They may include flushing, slight nasal irritation, headaches, or mild nausea
doi: 10.1111/acel.12262 63 Juiz-ValiaPPena-BelloLCordidoMOuteirio-BlancoEPrtegaSVarela-RodriguezBet al
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
Together, this layered strategy provides a framework for disease subtyping, early risk stratification, and identification of patients most likely to benefit from targeted interventions
They do a lot: regulate insulin secretion stimulate the gallbladder to release bile help with digestion and nutrient absorption keep food moving through and out of the body (known as gut motility) help regulate appetite and satiety (fullness) Some gut peptides you may have heard of: glucagon-like peptide 1 (GLP-1) glucose-dependent insulinotropic polypeptide (GIP) ghrelin (the hunger hormone) Gut peptides like GLP-1 and GIP lower blood sugar levels, which is also known as the incretin effect